Title | Type | SJR | H index | Total Docs. (2016) | Total Docs. (3years) | Total Refs. (2016) | Total Cites (3years) | Citable Docs. (3years) | Cites / Doc. (2years) | Ref. / Doc. (2016) | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|
1 | Nature Reviews Drug Discovery | journal | 12.597 Q1 | 391 | 257 | 625 | 8837 | 7380 | 260 | 11.64 | 34.39 | |
2 | Trends in Pharmacological Sciences | journal | 5.350 Q1 | 244 | 97 | 267 | 8367 | 2852 | 211 | 11.06 | 86.26 | |
3 | Neuropsychopharmacology | journal | 3.747 Q1 | 249 | 323 | 906 | 18423 | 5916 | 859 | 6.06 | 57.04 | |
4 | Journal for ImmunoTherapy of Cancer | journal | 2.668 Q1 | 117 | 90 | 146 | 3979 | 767 | 138 | 5.18 | 44.21 | |
5 | Neuropharmacology | journal | 2.355 Q1 | 191 | 433 | 1229 | 30501 | 6354 | 1206 | 5.25 | 70.44 | |
6 | Journal of Antimicrobial Chemotherapy | journal | 2.283 Q1 | 221 | 579 | 1597 | 17638 | 7321 | 1368 | 4.61 | 30.46 | |
7 | Drug Discovery Today | journal | 2.170 Q1 | 215 | 209 | 586 | 15377 | 3856 | 544 | 6.41 | 73.57 | |
8 | Journal of Psychopharmacology | journal | 2.095 Q1 | 135 | 140 | 391 | 8640 | 1810 | 372 | 4.69 | 61.71 | |
9 | International Journal of Neuropsychopharmacology | journal | 1.997 Q1 | 125 | 118 | 598 | 6544 | 2678 | 587 | 4.38 | 55.46 | |
10 | PharmacoEconomics | journal | 1.797 Q1 | 118 | 112 | 311 | 4712 | 1002 | 258 | 3.45 | 42.07 | |
11 | Expert Opinion on Therapeutic Targets | journal | 1.765 Q1 | 106 | 119 | 377 | 12656 | 1702 | 366 | 4.53 | 106.35 | |
12 | Clinical Trials | journal | 1.623 Q1 | 74 | 96 | 290 | 1871 | 527 | 238 | 1.92 | 19.49 | |
13 | Clinical Pharmacokinetics | journal | 1.599 Q1 | 184 | 110 | 269 | 6748 | 1381 | 244 | 4.68 | 61.35 | |
14 | CNS Neuroscience and Therapeutics | journal | 1.567 Q1 | 91 | 128 | 425 | 6031 | 1514 | 324 | 3.34 | 47.12 | |
15 | British Journal of Clinical Pharmacology | journal | 1.543 Q1 | 167 | 297 | 820 | 12341 | 3147 | 713 | 3.44 | 41.55 | |
16 | Expert Review of Vaccines | journal | 1.482 Q1 | 105 | 141 | 416 | 11331 | 1366 | 386 | 3.31 | 80.36 | |
17 | Drug Safety | journal | 1.454 Q1 | 140 | 105 | 313 | 5877 | 1117 | 270 | 3.47 | 55.97 | |
18 | Therapeutic Advances in Neurological Disorders | journal | 1.442 Q1 | 68 | 47 | 86 | 2043 | 394 | 82 | 4.87 | 43.47 | |
19 | Pharmacogenomics Journal | journal | 1.377 Q1 | 95 | 76 | 227 | 3861 | 966 | 227 | 3.87 | 50.80 | |
20 | Acta Pharmacologica Sinica | journal | 1.250 Q1 | 117 | 163 | 509 | 7570 | 1834 | 503 | 3.02 | 46.44 | |
21 | Antiviral Therapy | journal | 1.247 Q1 | 93 | 96 | 349 | 2850 | 877 | 339 | 2.34 | 29.69 | |
22 | Expert Opinion on Investigational Drugs | journal | 1.210 Q1 | 117 | 126 | 411 | 11124 | 1545 | 405 | 3.80 | 88.29 | |
23 | Expert Opinion on Biological Therapy | journal | 1.167 Q1 | 102 | 139 | 502 | 11318 | 1752 | 489 | 3.43 | 81.42 | |
24 | ChemMedChem | journal | 1.156 | 119 | 320 | 780 | 13373 | 2163 | 771 | 2.80 | 41.79 | |
25 | Journal of Cardiovascular Pharmacology and Therapeutics | journal | 1.127 Q1 | 57 | 59 | 184 | 2833 | 510 | 179 | 2.95 | 48.02 | |
26 | Cardiovascular Therapeutics | journal | 1.095 Q1 | 54 | 58 | 168 | 2165 | 424 | 161 | 2.53 | 37.33 | |
27 | Expert Opinion on Therapeutic Patents | journal | 1.057 Q2 | 88 | 110 | 328 | 9821 | 1305 | 325 | 3.16 | 89.28 | |
28 | BioDrugs | journal | 1.035 Q2 | 79 | 48 | 139 | 2995 | 476 | 131 | 3.18 | 62.40 | |
29 | Phytotherapy Research | journal | 1.016 Q2 | 158 | 217 | 775 | 11891 | 2794 | 770 | 3.61 | 54.80 | |
30 | Expert Opinion on Pharmacotherapy | journal | 1.014 Q2 | 93 | 238 | 734 | 17781 | 2325 | 715 | 3.40 | 74.71 | |
31 | Pharmaceutical Statistics | journal | 1.004 Q2 | 46 | 55 | 152 | 1667 | 195 | 145 | 1.22 | 30.31 | |
32 | Future Medicinal Chemistry | journal | 0.970 Q2 | 90 | 165 | 564 | 11139 | 1450 | 450 | 2.63 | 67.51 | |
33 | BMC pharmacology & toxicology | journal | 0.940 Q2 | 43 | 62 | 180 | 2499 | 525 | 177 | 2.81 | 40.31 | |
34 | Expert Opinion on Drug Metabolism and Toxicology | journal | 0.928 Q2 | 100 | 138 | 403 | 11225 | 1389 | 399 | 3.40 | 81.34 | |
35 | MedChemComm | journal | 0.913 | 0 | 0 | 0 | 0 | 0 | 0 | 0.00 | 0.00 | |
36 | Pharmacogenomics | journal | 0.904 Q2 | 100 | 177 | 606 | 9598 | 1438 | 528 | 2.25 | 54.23 | |
37 | Journal of Enzyme Inhibition and Medicinal Chemistry | journal | 0.873 Q2 | 92 | 317 | 427 | 14565 | 1503 | 426 | 3.71 | 45.95 | |
38 | Clinical and Experimental Pharmacology and Physiology | journal | 0.845 Q2 | 115 | 152 | 424 | 6290 | 898 | 400 | 2.04 | 41.38 | |
39 | Fundamental and Clinical Pharmacology | journal | 0.840 Q2 | 85 | 64 | 212 | 2749 | 548 | 211 | 2.45 | 42.95 | |
40 | Chemical Biology and Drug Design | journal | 0.812 | 91 | 181 | 537 | 7063 | 1423 | 531 | 2.33 | 39.02 | |
41 | Molecular Diagnosis and Therapy | journal | 0.806 Q2 | 68 | 59 | 164 | 3036 | 408 | 158 | 2.07 | 51.46 | |
42 | Expert Opinion on Emerging Drugs | journal | 0.762 Q2 | 54 | 38 | 131 | 3609 | 377 | 127 | 3.21 | 94.97 | |
43 | Journal of Pharmacy and Pharmacology | journal | 0.740 Q2 | 137 | 155 | 526 | 6760 | 1451 | 520 | 2.48 | 43.61 | |
44 | Journal of Antibiotics | journal | 0.733 Q2 | 92 | 143 | 408 | 4036 | 946 | 387 | 2.31 | 28.22 | |
45 | Drugs in Context | journal | 0.718 Q2 | 36 | 11 | 40 | 375 | 118 | 36 | 3.81 | 34.09 | |
46 | Journal of Veterinary Pharmacology and Therapeutics | journal | 0.716 Q2 | 67 | 86 | 258 | 2671 | 348 | 255 | 1.23 | 31.06 | |
47 | Biopharmaceutics and Drug Disposition | journal | 0.681 Q2 | 65 | 48 | 147 | 1600 | 385 | 144 | 2.17 | 33.33 | |
48 | Journal of Clinical Pharmacy and Therapeutics | journal | 0.669 Q2 | 81 | 123 | 332 | 3406 | 700 | 330 | 1.94 | 27.69 | |
49 | Journal of Peptide Science | journal | 0.655 Q2 | 73 | 87 | 326 | 3779 | 584 | 320 | 2.01 | 43.44 | |
50 | DARU, Journal of Pharmaceutical Sciences | journal | 0.614 Q3 | 58 | 24 | 211 | 747 | 475 | 194 | 2.05 | 31.13 |
Follow us on @ScimagoJR
Scimago Lab, Copyright 2007-2024. Data Source: Scopus®